BridgeBio Pharma, Inc. Quarterly Interest Expense in USD from Q3 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
BridgeBio Pharma, Inc. quarterly/annual Interest Expense history and growth rate from Q3 2018 to Q2 2024.
  • BridgeBio Pharma, Inc. Interest Expense for the quarter ending June 30, 2024 was $22.9M, a 11.4% increase year-over-year.
  • BridgeBio Pharma, Inc. Interest Expense for the twelve months ending June 30, 2024 was $87M, a 8.01% increase year-over-year.
  • BridgeBio Pharma, Inc. annual Interest Expense for 2023 was $81.3M, a 1.06% increase from 2022.
  • BridgeBio Pharma, Inc. annual Interest Expense for 2022 was $80.4M, a 72% increase from 2021.
  • BridgeBio Pharma, Inc. annual Interest Expense for 2021 was $46.8M, a 27.6% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $87M $22.9M +$2.34M +11.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $84.6M $23.5M +$3.35M +16.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $81.3M $20.3M +$278K +1.39% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $81M $20.3M +$481K +2.43% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $80.5M $20.6M +$315K +1.55% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $80.2M $20.1M -$223K -1.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $80.4M $20M +$4.86M +32.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $75.6M $19.8M +$8.76M +79.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $66.8M $20.3M +$9.44M +87.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $57.4M $20.3M +$10.6M +109% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $46.8M $15.1M +$4.17M +38.1% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 $42.6M $11.1M +$138K +1.26% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $42.5M $10.8M +$85K +0.79% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $42.4M $9.74M +$5.73M +143% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $36.7M $11M +$7.92M +261% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 $28.7M $10.9M +$8.82M +417% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $19.9M $10.8M +$8.81M +454% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $11.1M $4.01M +$2.34M +140% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $8.77M $3.04M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 $2.11M +$957K +82.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $1.94M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 $1.67M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q3 2018 $1.16M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.